Abstract

Non-coding RNAs (ncRNAs) have emerged as crucial regulators of gene expression and cellular processes, playing a significant role in breast cancer pathogenesis. This article explores the diverse classes of ncRNAs, including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), and their dysregulation in breast cancer. Dysregulated ncRNAs contribute to tumorigenesis, metastasis, and therapeutic resistance by modulating key signaling pathways. Additionally, ncRNAs hold promise as diagnostic and prognostic biomarkers, and as therapeutic targets for innovative treatment strategies. Understanding the intricate regulatory networks orchestrated by ncRNAs provides insights into breast cancer biology and offers avenues for personalized approaches to breast cancer management.